Last updated on August 2018

Post-Marketing Surveillance Study of Aripiprazole in Patients With Autism


Brief description of study

The purpose of this study is to evaluate the safety and effectiveness of aripiprazole in patients with autism in the real world clinical setting in Japan.

Clinical Study Identifier: NCT03179787

Contact Investigators or Research Sites near you

Start Over

Katsunaka Mikami, MD

Tokai Univ.
Isehara, Japan
6.91miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.